TY  - JOUR
TI  - ADVANTAGES OF A NEW PARADIGM OF EXPERIMENTAL ONCOLOGY: INDIVIDUAL PROGNOSIS OF IMMUNOTHERAPY OUTCOME BASED ON SURROGATE MARKER ANALYSIS
AU  - Moiseeva E.V.
AU  - Aronov D.A.
AU  - Semushina S.G.
AU  - Bozhenko V.K.
JO  - Molecular Medicine
PY  - 2014
IS  - 2
UR  - https://new.molmedjournal.ru/en/molecmed-2014-02-10
ER  -